EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $235,000 | -14.9% | 5,400 | -1.8% | 0.01% | -14.3% |
Q1 2022 | $276,000 | -1.4% | 5,500 | 0.0% | 0.01% | +16.7% |
Q4 2021 | $280,000 | -10.3% | 5,500 | -1.8% | 0.01% | -25.0% |
Q3 2021 | $312,000 | +37.4% | 5,600 | +5.7% | 0.01% | +33.3% |
Q2 2021 | $227,000 | +2.7% | 5,300 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $221,000 | -10.5% | 5,300 | 0.0% | 0.01% | -14.3% |
Q4 2020 | $247,000 | +3.8% | 5,300 | -5.4% | 0.01% | -36.4% |
Q3 2020 | $238,000 | +15.5% | 5,600 | +63.3% | 0.01% | +10.0% |
Q4 2019 | $206,000 | -1.4% | 3,430 | -7.3% | 0.01% | -9.1% |
Q3 2019 | $209,000 | +1.5% | 3,700 | -2.6% | 0.01% | +10.0% |
Q2 2019 | $206,000 | -39.4% | 3,800 | -22.4% | 0.01% | -33.3% |
Q3 2018 | $340,000 | +21.4% | 4,900 | +32.4% | 0.02% | +15.4% |
Q2 2018 | $280,000 | +34.0% | 3,700 | +5.7% | 0.01% | +30.0% |
Q3 2017 | $209,000 | -17.1% | 3,500 | +9.4% | 0.01% | -16.7% |
Q2 2017 | $252,000 | -8.0% | 3,200 | -3.0% | 0.01% | -14.3% |
Q1 2017 | $274,000 | +7.9% | 3,300 | +3.1% | 0.01% | +7.7% |
Q4 2016 | $254,000 | +3.7% | 3,200 | -8.6% | 0.01% | 0.0% |
Q3 2016 | $245,000 | – | 3,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |